SLS
Sellas Life Sciences Group Inc
11.30$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +200.0% | -66.7% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | – | – | – | – | – | +29.9% | +0.0% | -100.0% | – | -92.1% | -18.0% | +152.4% | -51.7% | -13.0% | +81.6% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +194.7% | -67.9% | -100.0% | – | – | -109.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.4% | -48.9% | -13.5% | -53.5% | -25.3% | +154.1% | -11.8% | +8.0% | +667.5% | -85.9% | -25.7% | +30.3% | +182.3% | -63.3% | +22.3% | +3.8% | +17.1% | +54.6% | -19.3% | +31.4% | -25.3% | +35.9% | +19.9% | -22.6% | +36.5% | +22.7% | -17.4% | -1.9% | -12.3% | +0.3% | +1.5% | -15.9% | +1.7% | -27.8% | +20.8% | +8.9% | +12.2% | +8.4% | +22.3% | – | |
| – | -11.6% | +8.3% | +5.2% | +22.5% | +70.5% | -35.2% | +26.5% | -72.7% | +97.0% | -5.4% | +5.5% | -9.6% | +0.6% | -8.3% | -9.7% | +6.9% | +54.7% | +8.3% | -21.5% | -12.9% | +3.7% | +19.7% | +2.3% | -7.4% | +25.7% | +14.1% | -23.9% | +13.5% | -13.2% | +47.2% | -46.3% | +21.8% | -16.4% | +15.2% | +5.0% | -4.5% | +23.0% | +17.0% | +5.7% | – | |
| – | +10.2% | -28.7% | -3.5% | -9.1% | +50.0% | -15.1% | +14.4% | -52.9% | +417.6% | -72.5% | -7.8% | +4.1% | +379.0% | -79.7% | +5.0% | +5.3% | +34.9% | +29.5% | -20.3% | +11.6% | -15.2% | +29.0% | +12.9% | -17.1% | +32.2% | +19.4% | -19.8% | +3.4% | -12.6% | +18.0% | -21.0% | -3.8% | -5.6% | -12.4% | +13.4% | +3.1% | +16.5% | +12.1% | +14.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.4% | -36.0% | -29.4% | -17.8% | +212.0% | -94.6% | +27.1% | -39.3% | -64.9% | -46.2% | +28.6% | +227.8% | +100.0% | -79.7% | – | – | – | – | – | – | – | -100.0% | +2,200.0% | +141.3% | +373.0% | -65.0% | +13.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -46.8% | +2,628.4% | -98.2% | -46.2% | +301.6% | -62.1% | +69.8% | +5,510.4% | -116.9% | – | – | +663.4% | -101.1% | – | – | – | – | – | – | – | – | – | -3,742.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -427.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -281.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,722.6% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.